Variant Bio is developing therapies that will improve global health by studying the genes of people who are outliers for medically relevant traits.
| Website | http://www.variantbio.com |
| Employees | 37 (32 on RocketReach) |
| Founded | 2018 |
| Address | 188 E Blaine St Suite 126, Seattle, Washington 98102, US |
| Technologies |
JavaScript
,
Twitter
,
Google Tag Manager
+14 more
(view full list)
|
| Industry | Biotechnology Research, Drug Discovery, Biotechnology |
| Keywords | Precision Medicine, Gene Therapy, Rare Diseases, Human Genetics, Personalized Medicine, Genome Editing, Drug Discovery, Genetic Engineering, Genetic Research, Pharmaceutical Research, Therapeutics, Molecular Biology, Biotechnology, Biomedical Research, Biopharma, Clinical Trials, Medical Research, Health Technology, Life Sciences |
| Competitors | Regeneron, Vertex Pharmaceuticals, Illumina, Alnylam Pharmaceuticals, CRISPR Therapeutics, Amgen, bluebird bio, Editas Medicine, Sangamo Therapeutics, Inc., Moderna Therapeutics +36 more (view full list) |
Looking for a particular Variant Bio employee's phone or email?
Andrew Farnum is the CEO of Variant Bio.
32 people are employed at Variant Bio.
Variant Bio is based in Seattle, Washington.